US Stock MarketDetailed Quotes

Aurinia Pharmaceuticals (AUPH)

Watchlist
  • 15.980
  • -0.160-0.99%
Close Apr 24 15:59 ET
  • 15.768
  • -0.212-1.32%
Post 20:01 ET
2.08BMarket Cap7.72P/E (TTM)

Aurinia Pharmaceuticals (AUPH) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
20.38%283.06M
28.81%77.11M
8.41%73.47M
22.41%70.01M
24.18%62.47M
33.97%235.13M
32.76%59.87M
24.32%67.77M
37.83%57.19M
46.19%50.3M
Operating revenue
20.38%283.06M
28.81%77.11M
8.41%73.47M
22.41%70.01M
24.18%62.47M
33.97%235.13M
32.76%59.87M
24.32%67.77M
37.83%57.19M
46.19%50.3M
Cost of revenue
15.64%32.67M
58.48%8.8M
35.49%8.18M
-20.14%7.12M
10.60%8.57M
99.66%28.25M
2.91%5.55M
-10.84%6.04M
469.99%8.91M
1,741.33%7.75M
Gross profit
21.03%250.39M
25.78%68.32M
5.76%65.29M
30.26%62.89M
26.65%53.89M
28.21%206.89M
36.81%54.32M
29.30%61.74M
20.92%48.28M
25.19%42.55M
Operating expense
-23.68%143.83M
-13.68%35.08M
-28.89%35.55M
-12.37%42.7M
-37.89%30.51M
-25.52%188.47M
-41.43%40.63M
-21.90%49.99M
-13.15%48.72M
-22.73%49.12M
Selling and administrative expenses
-40.83%101.79M
-21.00%29.26M
-38.20%26.18M
-42.10%26.02M
-57.36%20.34M
-11.80%172.03M
-38.91%37.03M
-4.74%42.37M
2.96%44.93M
3.01%47.7M
-Selling and marketing expense
-77.24%3.21M
-62.35%785K
-86.57%605K
-79.93%848K
-70.41%970K
-22.93%14.09M
--2.09M
--4.51M
--4.23M
--3.28M
-General and administrative expense
-37.58%98.59M
-18.53%28.47M
-32.45%25.58M
-38.17%25.17M
-56.39%19.37M
-19.02%157.93M
-42.35%34.95M
-14.87%37.86M
-6.72%40.71M
-4.07%44.42M
Research and development costs
56.39%32.51M
34.39%10.9M
176.83%8.44M
82.16%7.43M
3.46%5.74M
-58.13%20.79M
-20.74%8.11M
-77.60%3.05M
-67.75%4.08M
-57.81%5.55M
Depreciation amortization depletion
----
----
----
----
----
----
----
-16.93%2.73M
-22.82%2.66M
-25.64%2.84M
-Depreciation and amortization
----
----
----
----
----
----
----
-16.93%2.73M
-22.82%2.66M
-25.64%2.84M
Other operating expenses
319.23%9.53M
-12.61%-5.07M
-79.69%929K
3,288.28%9.25M
207.37%4.43M
-151.88%-4.35M
-149.66%-4.51M
72.93%4.57M
92.01%-290K
-1,522.41%-4.13M
Operating profit
478.54%106.56M
142.94%33.24M
153.19%29.75M
4,679.82%20.2M
455.86%23.38M
120.09%18.42M
146.11%13.68M
172.24%11.75M
97.27%-441K
77.79%-6.57M
Net non-operating interest income expense
-23.83%9.24M
-13.76%2.45M
-27.53%2.22M
-30.69%2.07M
-22.85%2.5M
-14.67%12.14M
-12.77%2.84M
-1.77%3.06M
-25.89%2.99M
-14.97%3.24M
Non-operating interest income
-20.02%13.57M
-12.29%3.5M
-22.29%3.32M
-23.85%3.19M
-21.14%3.57M
-0.16%16.97M
-12.70%3.99M
-5.47%4.27M
2.15%4.19M
18.67%4.53M
Non-operating interest expense
-10.44%4.33M
-8.64%1.05M
-9.02%1.1M
-6.76%1.12M
-16.84%1.07M
74.23%4.84M
-12.52%1.15M
-13.71%1.21M
1,743.08%1.2M
--1.28M
Other net income (expense)
92.87%-1.65M
0
89.37%-114K
77.06%-1.53M
-23.11M
-15.35M
-1.07M
-6.68M
Special income (charges)
92.87%-1.65M
--0
--0
89.37%-114K
77.06%-1.53M
---23.11M
---15.35M
--0
---1.07M
---6.68M
-Less:Restructuring and merger&acquisition
-92.87%1.65M
--0
--0
-89.37%114K
-77.06%1.53M
--23.11M
--15.35M
--0
--1.07M
--6.68M
-Less:Other special charges
----
----
----
----
----
----
----
----
--186K
--919K
Income before tax
1,432.72%114.16M
2,942.63%35.69M
115.86%31.96M
1,399.05%22.16M
343.25%24.35M
109.61%7.45M
104.44%1.17M
212.61%14.81M
112.18%1.48M
61.16%-10.01M
Income tax
-10,303.13%-173.05M
-68,300.00%-175.1M
-10.07%411K
-14.95%643K
35.99%1.01M
207.80%1.7M
-155.77%-256K
53.36%457K
217.76%756K
69.50%739K
Net income
4,893.08%287.2M
14,651.15%210.79M
119.87%31.55M
2,879.64%21.51M
317.17%23.34M
107.37%5.75M
105.32%1.43M
206.72%14.35M
106.28%722K
58.98%-10.75M
Net income continuous Operations
4,893.08%287.2M
14,651.15%210.79M
119.87%31.55M
2,879.64%21.51M
317.17%23.34M
107.37%5.75M
105.32%1.43M
206.72%14.35M
106.28%722K
58.98%-10.75M
Minority interest income
Net income attributable to the parent company
4,893.08%287.2M
14,651.15%210.79M
119.87%31.55M
2,879.64%21.51M
317.17%23.34M
107.37%5.75M
105.32%1.43M
206.72%14.35M
106.28%722K
58.98%-10.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4,893.08%287.2M
14,651.15%210.79M
119.87%31.55M
2,879.64%21.51M
317.17%23.34M
107.37%5.75M
105.32%1.43M
206.72%14.35M
106.28%722K
58.98%-10.75M
Basic earnings per share
5,250.00%2.14
15,900.00%1.6
140.00%0.24
1,500.00%0.16
328.57%0.16
107.41%0.04
105.56%0.01
211.11%0.1
112.50%0.01
61.11%-0.07
Diluted earnings per share
5,075.00%2.07
15,200.00%1.53
130.00%0.23
1,500.00%0.16
328.57%0.16
107.41%0.04
105.56%0.01
211.11%0.1
112.50%0.01
61.11%-0.07
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 20.38%283.06M28.81%77.11M8.41%73.47M22.41%70.01M24.18%62.47M33.97%235.13M32.76%59.87M24.32%67.77M37.83%57.19M46.19%50.3M
Operating revenue 20.38%283.06M28.81%77.11M8.41%73.47M22.41%70.01M24.18%62.47M33.97%235.13M32.76%59.87M24.32%67.77M37.83%57.19M46.19%50.3M
Cost of revenue 15.64%32.67M58.48%8.8M35.49%8.18M-20.14%7.12M10.60%8.57M99.66%28.25M2.91%5.55M-10.84%6.04M469.99%8.91M1,741.33%7.75M
Gross profit 21.03%250.39M25.78%68.32M5.76%65.29M30.26%62.89M26.65%53.89M28.21%206.89M36.81%54.32M29.30%61.74M20.92%48.28M25.19%42.55M
Operating expense -23.68%143.83M-13.68%35.08M-28.89%35.55M-12.37%42.7M-37.89%30.51M-25.52%188.47M-41.43%40.63M-21.90%49.99M-13.15%48.72M-22.73%49.12M
Selling and administrative expenses -40.83%101.79M-21.00%29.26M-38.20%26.18M-42.10%26.02M-57.36%20.34M-11.80%172.03M-38.91%37.03M-4.74%42.37M2.96%44.93M3.01%47.7M
-Selling and marketing expense -77.24%3.21M-62.35%785K-86.57%605K-79.93%848K-70.41%970K-22.93%14.09M--2.09M--4.51M--4.23M--3.28M
-General and administrative expense -37.58%98.59M-18.53%28.47M-32.45%25.58M-38.17%25.17M-56.39%19.37M-19.02%157.93M-42.35%34.95M-14.87%37.86M-6.72%40.71M-4.07%44.42M
Research and development costs 56.39%32.51M34.39%10.9M176.83%8.44M82.16%7.43M3.46%5.74M-58.13%20.79M-20.74%8.11M-77.60%3.05M-67.75%4.08M-57.81%5.55M
Depreciation amortization depletion -----------------------------16.93%2.73M-22.82%2.66M-25.64%2.84M
-Depreciation and amortization -----------------------------16.93%2.73M-22.82%2.66M-25.64%2.84M
Other operating expenses 319.23%9.53M-12.61%-5.07M-79.69%929K3,288.28%9.25M207.37%4.43M-151.88%-4.35M-149.66%-4.51M72.93%4.57M92.01%-290K-1,522.41%-4.13M
Operating profit 478.54%106.56M142.94%33.24M153.19%29.75M4,679.82%20.2M455.86%23.38M120.09%18.42M146.11%13.68M172.24%11.75M97.27%-441K77.79%-6.57M
Net non-operating interest income expense -23.83%9.24M-13.76%2.45M-27.53%2.22M-30.69%2.07M-22.85%2.5M-14.67%12.14M-12.77%2.84M-1.77%3.06M-25.89%2.99M-14.97%3.24M
Non-operating interest income -20.02%13.57M-12.29%3.5M-22.29%3.32M-23.85%3.19M-21.14%3.57M-0.16%16.97M-12.70%3.99M-5.47%4.27M2.15%4.19M18.67%4.53M
Non-operating interest expense -10.44%4.33M-8.64%1.05M-9.02%1.1M-6.76%1.12M-16.84%1.07M74.23%4.84M-12.52%1.15M-13.71%1.21M1,743.08%1.2M--1.28M
Other net income (expense) 92.87%-1.65M089.37%-114K77.06%-1.53M-23.11M-15.35M-1.07M-6.68M
Special income (charges) 92.87%-1.65M--0--089.37%-114K77.06%-1.53M---23.11M---15.35M--0---1.07M---6.68M
-Less:Restructuring and merger&acquisition -92.87%1.65M--0--0-89.37%114K-77.06%1.53M--23.11M--15.35M--0--1.07M--6.68M
-Less:Other special charges ----------------------------------186K--919K
Income before tax 1,432.72%114.16M2,942.63%35.69M115.86%31.96M1,399.05%22.16M343.25%24.35M109.61%7.45M104.44%1.17M212.61%14.81M112.18%1.48M61.16%-10.01M
Income tax -10,303.13%-173.05M-68,300.00%-175.1M-10.07%411K-14.95%643K35.99%1.01M207.80%1.7M-155.77%-256K53.36%457K217.76%756K69.50%739K
Net income 4,893.08%287.2M14,651.15%210.79M119.87%31.55M2,879.64%21.51M317.17%23.34M107.37%5.75M105.32%1.43M206.72%14.35M106.28%722K58.98%-10.75M
Net income continuous Operations 4,893.08%287.2M14,651.15%210.79M119.87%31.55M2,879.64%21.51M317.17%23.34M107.37%5.75M105.32%1.43M206.72%14.35M106.28%722K58.98%-10.75M
Minority interest income
Net income attributable to the parent company 4,893.08%287.2M14,651.15%210.79M119.87%31.55M2,879.64%21.51M317.17%23.34M107.37%5.75M105.32%1.43M206.72%14.35M106.28%722K58.98%-10.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4,893.08%287.2M14,651.15%210.79M119.87%31.55M2,879.64%21.51M317.17%23.34M107.37%5.75M105.32%1.43M206.72%14.35M106.28%722K58.98%-10.75M
Basic earnings per share 5,250.00%2.1415,900.00%1.6140.00%0.241,500.00%0.16328.57%0.16107.41%0.04105.56%0.01211.11%0.1112.50%0.0161.11%-0.07
Diluted earnings per share 5,075.00%2.0715,200.00%1.53130.00%0.231,500.00%0.16328.57%0.16107.41%0.04105.56%0.01211.11%0.1112.50%0.0161.11%-0.07
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More